Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q3 EPS of ($0.30), $0.05 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.